share_log

藥明巨諾-B：翌日披露報表

JW THERAP-B: Next Day Disclosure Return

香港交易所 ·  Apr 2 07:36
Summary by Moomoo AI
藥明巨諾-B（02126.HK）於2024年4月2日根據《香港聯合交易所有限公司證券上市規則》披露已發行股本變動。該公司在股份獎勵計劃下發行了1,203,121股普通股，佔其發行前已發行股份的0.2912%，每股發行價為0.000078港元，較上一個營業日收市價1.83港元的折讓幅度達99.996%。此次發行後，藥明巨諾-B的已發行股本增至414,358,958股。公司確認，所有相關法律及規定程序已遵守，並且已收取全部應得款項。
藥明巨諾-B（02126.HK）於2024年4月2日根據《香港聯合交易所有限公司證券上市規則》披露已發行股本變動。該公司在股份獎勵計劃下發行了1,203,121股普通股，佔其發行前已發行股份的0.2912%，每股發行價為0.000078港元，較上一個營業日收市價1.83港元的折讓幅度達99.996%。此次發行後，藥明巨諾-B的已發行股本增至414,358,958股。公司確認，所有相關法律及規定程序已遵守，並且已收取全部應得款項。
Yao Ming Ju-B (02126.HK) disclosed changes in issued share capital on April 2, 2024 pursuant to the Listing Rules of Securities of the Hong Kong Stock Exchange Limited. The Company issued 1,203,121 shares of ordinary shares under the Share Award Scheme, representing 0.2912% of its pre-issue shares at an issue price of HK$0.000078 per share, representing a 99.996% discount from the previous business day's market price of HK$1.83. Following the issuance, the issued share capital of YaMing Jelno-B increased to 414,358,958 shares. The Company confirms that all relevant laws and procedures have been complied with and that all monies due have been received.
Yao Ming Ju-B (02126.HK) disclosed changes in issued share capital on April 2, 2024 pursuant to the Listing Rules of Securities of the Hong Kong Stock Exchange Limited. The Company issued 1,203,121 shares of ordinary shares under the Share Award Scheme, representing 0.2912% of its pre-issue shares at an issue price of HK$0.000078 per share, representing a 99.996% discount from the previous business day's market price of HK$1.83. Following the issuance, the issued share capital of YaMing Jelno-B increased to 414,358,958 shares. The Company confirms that all relevant laws and procedures have been complied with and that all monies due have been received.
Helpful
Not Helpful

This announcement is a separate document:

Doc 1     View Translation

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more